|
Diabetes, Vol 48, Issue 9 1730-1736, Copyright © 1999 by American Diabetes Association
Adenoviral gene transfer of the interleukin-1 receptor antagonist protein to human islets prevents IL-1beta-induced beta-cell impairment and activation of islet cell apoptosis in vitro
N Giannoukakis, WA Rudert, SC Ghivizzani, A Gambotto, C Ricordi, M Trucco and PD Robbins
Department of Molecular Genetics and Biochemistry, Children's Hospital, University of Pittsburgh School of Medicine, Pennsylvania 15261, USA.
The beta-cells in the pancreatic islets of Langerhans are the targets of
autoreactive T-cells and are destroyed in type 1 diabetes.
Macrophage-derived interleukin-1beta (IL-1beta) is important in eliciting
beta-cell dysfunction and initiating beta-cell damage in response to
microenvironmental changes within islets. In particular, IL-1beta can
impair glucose-stimulated insulin production in beta-cells in vitro and can
sensitize them to Fas (CD95)/FasL-triggered apoptosis. In this report, we
have examined the ability to block the detrimental effects of IL-1beta by
genetically modifying islets by adenoviral gene transfer to express the
IL-1 receptor antagonist protein. We demonstrate that adenoviral gene
delivery of the cDNA encoding the interleukin-1 receptor antagonist protein
(IL-1Ra) to cultured islets results in protection of human islets in vitro
against IL-1beta-induced nitric oxide formation, impairment in
glucose-stimulated insulin production, and Fas-triggered apoptosis
activation. Our results further support the hypothesis that IL-1beta
antagonism in in situ may prevent intra-islet proinsulitic inflammatory
events and may allow for an in vivo gene therapy strategy to prevent
insulitis and the consequent pathogenesis of diabetes.

CiteULike Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
R. Takahashi, H. Ishihara, K. Takahashi, A. Tamura, S. Yamaguchi, T. Yamada, H. Katagiri, and Y. Oka
Efficient and controlled gene expression in mouse pancreatic islets by arterial delivery of tetracycline-inducible adenoviral vectors
J. Mol. Endocrinol.,
January 1, 2007;
38(1):
127 - 136.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. Maedler, D. M. Schumann, N. Sauter, H. Ellingsgaard, D. Bosco, R. Baertschiger, Y. Iwakura, J. Oberholzer, C. B. Wollheim, B. R. Gauthier, et al.
Low Concentration of Interleukin-1{beta} Induces FLICE-Inhibitory Protein-Mediated {beta}-Cell Proliferation in Human Pancreatic Islets.
Diabetes,
October 1, 2006;
55(10):
2713 - 2722.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H. Oshima, M. M. Taketo, and M. Oshima
Destruction of Pancreatic beta-Cells by Transgenic Induction of Prostaglandin E2 in the Islets
J. Biol. Chem.,
September 29, 2006;
281(39):
29330 - 29336.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. Liuwantara, M. Elliot, M. W. Smith, A. O. Yam, S. N. Walters, E. Marino, A. McShea, and S. T. Grey
Nuclear Factor-{kappa}B Regulates {beta}-Cell Death: A Critical Role for A20 in {beta}-Cell Protection
Diabetes,
September 1, 2006;
55(9):
2491 - 2501.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C.-C. Sun, J.-H. Su Pang, C.-Y. Cheng, H.-F. Cheng, Y.-S. Lee, W.-C. Ku, C.-H. Hsiao, J.-K. Chen, and C.-M. Yang
Interleukin-1 Receptor Antagonist (IL-1RA) Prevents Apoptosis in Ex Vivo Expansion of Human Limbal Epithelial Cells Cultivated on Human Amniotic Membrane
Stem Cells,
September 1, 2006;
24(9):
2130 - 2139.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. S. Narang and R. I. Mahato
Biological and biomaterial approaches for improved islet transplantation.
Pharmacol. Rev.,
June 1, 2006;
58(2):
194 - 243.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Z. Wang, T. Zhu, K. K. Rehman, S. Bertera, J. Zhang, C. Chen, G. Papworth, S. Watkins, M. Trucco, P. D. Robbins, et al.
Widespread and Stable Pancreatic Gene Transfer by Adeno-Associated Virus Vectors via Different Routes.
Diabetes,
April 1, 2006;
55(4):
875 - 884.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. R. Barbu, G. Akusjarvi, and N. Welsh
Adenoviral-Mediated Transduction of Human Pancreatic Islets: Importance of Adenoviral Genome for Cell Viability and Association with a Deficient Antiviral Response
Endocrinology,
May 1, 2005;
146(5):
2406 - 2414.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. Han, J. H. Bae, S.-Y. Kim, H.-Y. Lee, B.-C. Jang, I.-K. Lee, C.-H. Cho, J.-G. Lim, S.-I. Suh, T.-K. Kwon, et al.
Taurine increases glucose sensitivity of UCP2-overexpressing {beta}-cells by ameliorating mitochondrial metabolism
Am J Physiol Endocrinol Metab,
November 1, 2004;
287(5):
E1008 - E1018.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Y-H Suh, S-Y Kim, H-Y Lee, B C Jang, J H Bae, J-N Sohn, J-H Bae, S-I Suh, J-W Park, K-U Lee, et al.
Overexpression of short heterodimer partner recovers impaired glucose-stimulated insulin secretion of pancreatic {beta}-cells overexpressing UCP2
J. Endocrinol.,
October 1, 2004;
183(1):
133 - 144.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. K. Rehman, S. Bertera, R. Bottino, A. N. Balamurugan, J. C. Mai, Z. Mi, M. Trucco, and P. D. Robbins
Protection of Islets by in Situ Peptide-mediated Transduction of the Ikappa B Kinase Inhibitor Nemo-binding Domain Peptide
J. Biol. Chem.,
March 7, 2003;
278(11):
9862 - 9868.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. H. Von der Thusen, J. Kuiper, T. J. C. Van Berkel, and E. A. L. Biessen
Interleukins in Atherosclerosis: Molecular Pathways and Therapeutic Potential
Pharmacol. Rev.,
March 1, 2003;
55(1):
133 - 166.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Bertera, M. L. Crawford, A. M. Alexander, G. D. Papworth, S. C. Watkins, P. D. Robbins, and M. Trucco
Gene Transfer of Manganese Superoxide Dismutase Extends Islet Graft Function in a Mouse Model of Autoimmune Diabetes
Diabetes,
February 1, 2003;
52(2):
387 - 393.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. M. Alexander, M. Crawford, S. Bertera, W. A. Rudert, O. Takikawa, P. D. Robbins, and M. Trucco
Indoleamine 2,3-Dioxygenase Expression in Transplanted NOD Islets Prolongs Graft Survival After Adoptive Transfer of Diabetogenic Splenocytes
Diabetes,
February 1, 2002;
51(2):
356 - 365.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. Suzuki, B. Murtuza, R. T. Smolenski, I. A. Sammut, N. Suzuki, Y. Kaneda, and M. H. Yacoub
Overexpression of Interleukin-1 Receptor Antagonist Provides Cardioprotection Against Ischemia-Reperfusion Injury Associated With Reduction in Apoptosis
Circulation,
September 18, 2001;
104(90001):
I-308 - 313.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. Embury, D. Klein, A. Pileggi, M. Ribeiro, S. Jayaraman, R. D. Molano, C. Fraker, N. Kenyon, C. Ricordi, L. Inverardi, et al.
Proteins Linked to a Protein Transduction Domain Efficiently Transduce Pancreatic Islets
Diabetes,
August 1, 2001;
50(8):
1706 - 1713.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
N. Giannoukakis, W. A. Rudert, M. Trucco, and P. D. Robbins
Protection of Human Islets from the Effects of Interleukin-1beta by Adenoviral Gene Transfer of an Ikappa B Repressor
J. Biol. Chem.,
November 17, 2000;
275(47):
36509 - 36513.
[Abstract]
[Full Text]
[PDF]
|
 |
|
Copyright © 1999 by the American Diabetes Association.
|
|
| |
|